Congress today punted on legislation to regulate the growing CBD industry and set a safe level of daily consumption. The conference report directs funding for research, policy evaluation, market surveillance, and enforcement discretion related to CBD and hemp. Unlike…
“We look forward to working with Dr. Hahn and his staff to address much-needed regulation for cannabidiol (CBD) products and enforcement for adulterated dietary supplements," said Natural Products Association (NPA) President and CEO Dr. Daniel Fabricant, Ph.D.
The Natural Products Association today submitted comments to the House Energy and Commerce Committee regarding Good Manufacturing Practices (GMPs) for cosmetic products in advance of a Dec. 4, 2019 hearing entitled "Building Consumer Confidence by Empowering FDA to Improve…
In a letter to the U.S. Senate Health, Education, Labor, and Pensions Committee Chairman and Ranking Member, Natural Products Association (NPA) urges U.S. Senate to confirm Dr. Stephen Hahn as next Commissioner of the Food and Drug Administration (FDA).
New CBD Warning Letters and Consumer Update Won’t Protect Consumers from Public Health Crisis Without Real Action from FDA
NPA Continues to Call for Agency to Set Safe Level for Daily Use
The NPA Awards salute industry pioneers and leaders for their accomplishments in science, environmental issues, advocacy, social responsibility, and the industry at large.